MITOCHON PHARMACEUTICALS
Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Their development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrit... ion (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.
MITOCHON PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Radnor, Pennsylvania, United States
Country:
United States
Website Url:
http://www.mitochonpharma.com
Total Employee:
1+
Status:
Active
Total Funding:
2.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Boston Pharmaceuticals
Boston Pharmaceuticals Provides Healthcare Services.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Triptcor Pharmaceuticals
Triptcor Pharmaceuticals, a start-up based on inflammatory disease.
Current Employees Featured
Founder
Investors List
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Venture Round - Mitochon Pharmaceuticals
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - Mitochon Pharmaceuticals
Official Site Inspections
http://www.mitochonpharma.com Semrush global rank: 4.95 M Semrush visits lastest month: 1.73 K
- Host name: 271398.cloudwaysapps.com
- IP address: 69.55.49.48
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Mitochon Pharmaceuticals"
Mitochon Pharmaceuticals
Mitochon Pharmaceuticals is a clinical staged biotech company, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs.See details»
Our Mission - Mitochon Pharmaceuticals
Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by direct modulation of the mitochondria’s physiology to attenuate …See details»
Mitochon Pharmaceuticals - Ben Franklin Technology …
Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious …See details»
Management - Mitochon Pharmaceuticals
Robert Alonso, Founder & CEO – has 25 years of experience with both large pharmaceutical companies (Merck, Roche) and small biotech companies (Ceptaris).See details»
Mitochon Pharmaceuticals, Inc. | LinkedIn
Mitochon Pharmaceuticals is a clinically staged biotech that is focused on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs.See details»
MitoWorld
Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by direct modulation of the mitochondria’s physiology to attenuate disease progression. Website: …See details»
Mitochon Pharmaceuticals - Crunchbase Company …
View contacts for Mitochon Pharmaceuticals to access new leads and connect with decision-makers. Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria …See details»
Mitochon Pharmaceuticals Awarded Orphan Drug …
Mar 5, 2019 · BLUE BELL, Pa.-- ( BUSINESS WIRE )-- Mitochon Pharmaceuticals today announced that it was awarded Orphan Drug Designation by FDA for its mitochondrial targeted compound, MP-101 for treating...See details»
Mitochon Pharmaceuticals - Craft
See insights on Mitochon Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
European Medicines Agency (EMA) Greenlights Mitochon …
Jan 9, 2024 · Mitochon’s lead programs, MP101 and MP201, specifically harnesses the power of the mitochondria to provide broad neural protection (MOA:...See details»
Investors - Mitochon Pharmaceuticals
Mitochon is an early stage biopharmaceutical company and as such we are always interested in speaking with potential investors. Initial early investors include: Ben Franklin Technology Partners is one of the nation’s longest …See details»
Mitochon Pharmaceuticals - PitchBook
Operator of a biotechnology platform intended to develop drugs that target the mitochondria for a host of severe diseases with significant unmet medical needs.See details»
Mitochon Pharmaceuticals receives approval from EMA to initiate …
Jan 11, 2024 · MP101 is an oral brain penetrant mitochondrial stimulator, that improves central nervous system survival and function. Participants will receive MP101 once daily in this 14-day …See details»
Mitochon Pharmaceuticals: Pioneering Brain Injury Solutions …
Sep 23, 2024 · Mitochon was founded in 2014 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to …See details»
Mitochon Pharmaceuticals - Overview, News & Similar companies ...
Feb 3, 2021 · View Mitochon Pharmaceuticals (www.mitochonpharma.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar …See details»
Mitochon Pharmaceuticals Awarded Orphan Drug Designation
Mar 5, 2019 · BLUE BELL, Pa.-- ( BUSINESS WIRE )-- Mitochon Pharmaceuticals today announced that it was awarded Orphan Drug Designation by FDA for its mitochondrial …See details»
Mitochon Pharmaceuticals Awarded Orphan Drug Designation
Mar 5, 2019 · Blue Bell, Pennsylvania (BUSINESS WIRE) — Mitochon Pharmaceuticals today announced that it was awarded Orphan Drug Designation by FDA for its mitochondrial …See details»
Mitochon Pharmaceuticals and University of Kentucky ... - Business …
Sep 28, 2021 · Mitochon was founded in 2015 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to …See details»
Science & Technology - Mitochon Pharmaceuticals
Our mission is to develop this platform for the treatment of truly time sensitive insidious diseases and open the door for new advances in areas with significant unmet medical need.See details»